Variant report

Variant	esv3512693
Chromosome Location	chr19:51415440-51418251
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:30)
CpG islands
(count:427)
Chromatin interactive
region (count:2)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:30 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr19:51416178-51416192	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCL11A	chr19:51416042-51416277	GM12878	blood:	n/a	n/a
3	BHLHE40	chr19:51416023-51416355	GM12878	blood:	n/a	chr19:51416232-51416248
4	BHLHE40	chr19:51416220-51416256	K562	blood:	n/a	chr19:51416232-51416248
5	EBF1	chr19:51416006-51416389	GM12878	blood:	n/a	n/a
6	EBF1	chr19:51416169-51416266	GM12878	blood:	n/a	n/a
7	EGR1	chr19:51416063-51416277	K562	blood:	n/a	chr19:51416184-51416199
8	EGR1	chr19:51416062-51416360	K562	blood:	n/a	chr19:51416184-51416199
9	EP300	chr19:51416129-51416333	GM12878	blood:	n/a	chr19:51416208-51416217
10	EP300	chr19:51416101-51416321	GM12878	blood:	n/a	chr19:51416208-51416217
11	FOXA2	chr19:51415588-51416061	A549	lung:	n/a	n/a
12	IRF4	chr19:51417223-51417545	GM12878	blood:	n/a	n/a
13	IRF4	chr19:51416647-51417130	GM12878	blood:	n/a	n/a
14	IRF4	chr19:51416749-51417120	GM12878	blood:	n/a	n/a
15	IRF4	chr19:51417184-51417831	GM12878	blood:	n/a	n/a
16	JUND	chr19:51416034-51416312	K562	blood:	n/a	n/a
17	MAX	chr19:51416066-51416289	GM12878	blood:	n/a	n/a
18	MAZ	chr19:51416050-51416288	GM12878	blood:	n/a	n/a
19	MYC	chr19:51415985-51416012	H1-hESC	embryonic stem cell:	n/a	n/a
20	MYC	chr19:51415990-51416274	MCF-7	breast:	n/a	n/a
21	PAX5	chr19:51417330-51417510	GM12878	blood:	n/a	n/a
22	PAX5	chr19:51415964-51416375	GM12878	blood:	n/a	n/a
23	POLR2A	chr19:51417986-51418080	MCF10A-Er-Src	breast:	n/a	n/a
24	RUNX3	chr19:51415903-51416420	GM12878	blood:	n/a	n/a
25	RUNX3	chr19:51415991-51416402	GM12878	blood:	n/a	n/a
26	TBL1XR1	chr19:51416087-51416291	GM12878	blood:	n/a	n/a
27	TEAD4	chr19:51416078-51416448	H1-hESC	embryonic stem cell:	n/a	n/a
28	TEAD4	chr19:51416060-51416419	H1-hESC	embryonic stem cell:	n/a	n/a
29	ZBTB7A	chr19:51415985-51416131	K562	blood:	n/a	n/a
30	ZNF143	chr19:51416109-51416358	H1-hESC	embryonic stem cell:	n/a	chr19:51416208-51416218

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:51416098-51416148	HCT-116	colon:	n/a
2	chr19:51416517-51416567	Jurkat	blood:	n/a
3	chr19:51416202-51416252	NH-A	brain:	n/a
4	chr19:51415452-51415502	IMR90	lung:	fetal
5	chr19:51416202-51416252	SK-N-SH_RA	brain:	n/a
6	chr19:51416098-51416148	A549	lung:	n/a
7	chr19:51415450-51415500	ovcar-3	ovarian:	n/a
8	chr19:51415452-51415502	HRCEpiC	kidney:	n/a
9	chr19:51415452-51415502	HRPEpiC	eye:	n/a
10	chr19:51415450-51415500	A549	lung:	n/a
11	chr19:51416098-51416148	HRE	kidney:	n/a
12	chr19:51416098-51416148	MCF10A-Er-Src	breast:	n/a
13	chr19:51416010-51416060	SAEC	small airway:	n/a
14	chr19:51416213-51416263	SAEC	small airway:	n/a
15	chr19:51416010-51416060	NHBE	bronchial:	n/a
16	chr19:51416213-51416263	NT2-D1	testis:	n/a
17	chr19:51416517-51416567	AoSMC	blood vessel:	n/a
18	chr19:51416517-51416567	NB4	blood:	n/a
19	chr19:51416213-51416263	K562	blood:	n/a
20	chr19:51416010-51416060	HCT-116	colon:	n/a
21	chr19:51415452-51415502	GM12891	blood:	n/a
22	chr19:51416202-51416252	SK-N-SH	brain:	n/a
23	chr19:51416213-51416263	HCPEpiC	choroid plexus:	n/a
24	chr19:51416202-51416252	ovcar-3	ovarian:	n/a
25	chr19:51415452-51415502	GM06990	blood:	n/a
26	chr19:51415450-51415500	HNPCEpiC	eye:	n/a
27	chr19:51415450-51415500	Hela-S3	cervix:	n/a
28	chr19:51416010-51416060	U87	brain:	n/a
29	chr19:51416517-51416567	HRCEpiC	kidney:	n/a
30	chr19:51416213-51416263	BJ	skin:	n/a
31	chr19:51416517-51416567	HNPCEpiC	eye:	n/a
32	chr19:51416202-51416252	NT2-D1	testis:	n/a
33	chr19:51416517-51416567	K562	blood:	n/a
34	chr19:51416213-51416263	A549	lung:	n/a
35	chr19:51416010-51416060	HRCEpiC	kidney:	n/a
36	chr19:51416010-51416060	HRPEpiC	eye:	n/a
37	chr19:51416010-51416060	HL-60	blood:	n/a
38	chr19:51415450-51415500	H1-hESC	embryonic stem cell:	embryo
39	chr19:51416010-51416060	PrEC	prostate:	n/a
40	chr19:51416213-51416263	PFSK-1	brain:	n/a
41	chr19:51415452-51415502	HCT-116	colon:	n/a
42	chr19:51416010-51416060	AG04450	lung:	fetal
43	chr19:51416202-51416252	LNCaP	prostate:	n/a
44	chr19:51416517-51416567	PFSK-1	brain:	n/a
45	chr19:51415452-51415502	LNCaP	prostate:	n/a
46	chr19:51415450-51415500	AG04450	lung:	fetal
47	chr19:51416098-51416148	AG04449	skin:	fetal
48	chr19:51416098-51416148	GM12878	blood:	n/a
49	chr19:51416517-51416567	HepG2	liver:	n/a
50	chr19:51416010-51416060	RPTEC	kidney:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:51293560..51298277-chr19:51413419..51418761,7	K562	blood:
2	chr19:51413378..51415551-chr19:51610250..51611876,2	K562	blood:

No data

Variant related genes	Relation type
KLK4	TF binding region
KLK4	CpG island
ENSG00000268375	chromatin interactions
ENSG00000142544	chromatin interactions
ENSG00000142513	chromatin interactions

Extended variants
information (count: 171 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:171 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs184421915	chr19:51415450-51415451	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs542555359	chr19:51415500-51415501	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	CpG island Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
3	rs118154507	chr19:51415515-51415516	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs529650554	chr19:51415516-51415517	Bivalent Enhancer Bivalent/Poised TSS Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs572656952	chr19:51415600-51415601	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs150529448	chr19:51415629-51415630	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs3834625	chr19:51415651-51415652	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs74381785	chr19:51415658-51415659	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs59859603	chr19:51415667-51415668	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs370027399	chr19:51415668-51415669	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs564794946	chr19:51415673-51415674	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs532268319	chr19:51415674-51415675	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs550285720	chr19:51415681-51415682	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs148701654	chr19:51415705-51415706	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs529722155	chr19:51415759-51415760	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs548852227	chr19:51415761-51415762	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs3760734	chr19:51415791-51415792	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs34235231	chr19:51415809-51415810	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs112787788	chr19:51415830-51415831	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs369144577	chr19:51415834-51415835	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs367786737	chr19:51415918-51415919	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs570833562	chr19:51415923-51415924	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs78369039	chr19:51415979-51415980	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs111505749	chr19:51416019-51416020	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs115034065	chr19:51416042-51416043	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs368284260	chr19:51416043-51416044	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs151196806	chr19:51416066-51416067	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs140256054	chr19:51416086-51416087	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs558802501	chr19:51416088-51416089	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs565118338	chr19:51416089-51416090	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs199627859	chr19:51416113-51416114	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs111662856	chr19:51416114-51416115	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs71185776	chr19:51416117-51416118	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs3760735	chr19:51416118-51416119	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs3834626	chr19:51416119-51416120	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs111230924	chr19:51416123-51416124	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs373389306	chr19:51416126-51416127	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs529686540	chr19:51416186-51416187	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs3760736	chr19:51416194-51416195	Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs560749683	chr19:51416231-51416232	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs528012886	chr19:51416245-51416246	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs557159742	chr19:51416270-51416271	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs117319693	chr19:51416277-51416278	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
44	rs575634405	chr19:51416337-51416338	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
45	rs367955708	chr19:51416342-51416343	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
46	rs571063570	chr19:51416367-51416368	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
47	rs35286649	chr19:51416451-51416452	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs186077216	chr19:51416488-51416489	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs542608856	chr19:51416489-51416490	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs568239777	chr19:51416493-51416494	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD

Chromatin state (count:56 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:51410800-51418400	Weak transcription	Right Atrium	heart
2	chr19:51415200-51415600	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
3	chr19:51415200-51415800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr19:51415200-51415800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
5	chr19:51415200-51416200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
6	chr19:51415400-51415600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
7	chr19:51415400-51416200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr19:51415400-51416400	Bivalent Enhancer	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
9	chr19:51415600-51415800	Bivalent Enhancer	Lung	lung
10	chr19:51415600-51416400	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
11	chr19:51415600-51416600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
12	chr19:51415600-51416600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
13	chr19:51415800-51416000	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
14	chr19:51415800-51416000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
15	chr19:51415800-51416000	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
16	chr19:51415800-51416000	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
17	chr19:51415800-51416000	Bivalent Enhancer	A549	lung
18	chr19:51415800-51416400	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
19	chr19:51415800-51416400	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell
20	chr19:51415800-51416600	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
21	chr19:51415800-51416600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
22	chr19:51416000-51416200	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
23	chr19:51416000-51416200	Bivalent Enhancer	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr19:51416000-51416200	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
25	chr19:51416000-51416200	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
26	chr19:51416000-51416200	Flanking Bivalent TSS/Enh	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr19:51416000-51416200	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
28	chr19:51416000-51416200	Flanking Bivalent TSS/Enh	A549	lung
29	chr19:51416000-51416400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
30	chr19:51416000-51416400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
31	chr19:51416000-51416600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
32	chr19:51416000-51416600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
33	chr19:51416000-51416600	Bivalent Enhancer	HMEC	breast
34	chr19:51416000-51416800	Bivalent Enhancer	Esophagus	oesophagus
35	chr19:51416200-51416400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
36	chr19:51416200-51416400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
37	chr19:51416200-51416400	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
38	chr19:51416200-51416400	Bivalent Enhancer	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
39	chr19:51416200-51416400	Flanking Bivalent TSS/Enh	Breast Myoepithelial Primary Cells	Breast
40	chr19:51416200-51416400	Bivalent Enhancer	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr19:51416200-51416400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr19:51416200-51416400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
43	chr19:51416200-51416400	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
44	chr19:51416200-51416400	Bivalent Enhancer	Rectal Mucosa Donor 31	rectum
45	chr19:51416200-51416800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
46	chr19:51416400-51416600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
47	chr19:51416400-51416600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
48	chr19:51416400-51416600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
49	chr19:51416400-51416600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
50	chr19:51416400-51416600	Bivalent Enhancer	Stomach Smooth Muscle	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links